Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Low-Dose Naltrexone | Metformin XR | |
|---|---|---|
| Category | Pharmaceuticals | Pharmaceuticals |
| Standard Dose | — | — |
| Timing | — | — |
| Cycle Duration | — | — |
| Evidence Level | Emerging | Strong |
Transient opioid receptor blockade that may increase endogenous endorphin signaling and modulate immune tone in off-label protocols.
AMPK-activating insulin sensitizer that reduces hepatic glucose output and improves glycemic control. Also used in longevity-oriented discussion due metabolic effects.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →